Dual NK1/NK3 receptor antagonists for the treatment of schizophrenia

摘要

The present invention relates to a method of treating schizophrenia which comprises administering a therapeutically effective amount of a compound of formula I wherein R¹, R², and R³ are as defined in the specification or to pharmaceutically active acid-addition salts thereof.